Clinical Trials Directory

Trials / Completed

CompletedNCT00433602

Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors

TEACH Survey (Thrombo-Embolism And Chemotherapy) A Prospective Survey on the Incidence of Venous Thromboembolic Events During Chemotherapy for Solid Tumors

Status
Completed
Phase
Study type
Observational
Enrollment
64 (actual)
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Chemotherapy may cause blood clots to form in the thigh, leg, and lung. This study may help doctors understand how often blood clots occur in patients undergoing chemotherapy. PURPOSE: This clinical trial is studying how often blood clots occur in patients undergoing chemotherapy for solid tumors, including colorectal cancer, stomach cancer, lung cancer, ovarian cancer, pancreatic cancer, prostate cancer, or metastatic breast cancer

Detailed description

OBJECTIVES: * Determine the incidence of venous thromboembolic events (i.e., deep vein thrombosis and/or pulmonary embolism) in patients undergoing chemotherapy for solid tumors. OUTLINE: This is a prospective, multicenter survey. Patients undergo observation beginning on day 1 of chemotherapy and continuing for up to 3 months in the absence of symptomatic, confirmed deep vein thrombosis or pulmonary embolism; use of anticoagulant therapy for more than 5 days as curative treatment; or initiation of thromboprophylaxis for any reason. Patients undergo bilateral compression ultrasound of the lower limbs at baseline and at 3 months (or at an earlier timepoint, if indicated). PROJECTED ACCRUAL: A total of 2,000 patients will be accrued for this study.

Conditions

Interventions

TypeNameDescription
OTHERclinical observation
PROCEDUREmanagement of therapy complications
PROCEDUREultrasound imaging

Timeline

Start date
2006-11-01
Primary completion
2007-03-01
First posted
2007-02-12
Last updated
2013-06-12

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00433602. Inclusion in this directory is not an endorsement.